Introduction
The liver has the unique capacity to regenerate after removal of part of its cellular mass. During the last decade, much new information has become available on the events that may initiate liver regeneration. Several converging lines of evidence from recent works have proposed that Tumor necrosis factor-a (TNF-a) and are important components of the early signaling pathways leading to regeneration (Akerman et al., 1992; Yamada et al., 1997; Cressman et al., 1996) . Using mice harboring a targeted disruption of the gene encoding TNFR-1 (Rothe et al., 1993) and IL-6 (Poli et al., 1994) , it was shown that liver regeneration after 2/3 partial hepatectomy (PH) is severely impaired in both types of gene knock-out mice (Yamada et al., 1997; Cressman et al., 1996) . These results were interpreted to suggest that TNF, signaling through the TNFR-1, can initiate liver regeneration and acts by activating an IL-6-dependent pathway that involves STAT3 transcription factor. Hepatocytes, however can be stimulated to proliferate by treatment with a variety of agents such as triiodothyronine, retinoic acid, peroxisome proliferators, lead nitrate and barbiturates that do not cause tissue loss/injury, but rather an excess of cells . Unlike compensatory regeneration observed after 2/3 PH or chemically-induced cell necrosis, direct hyperplasia induced by primary mitogens is neither accompanied by increased hepatic mRNA levels of growth factor genes such as TGF-a and HGF (Ohmura et al., 1996) , nor by increased levels of circulating HGF (Kubo et al., 1996) . These ®ndings suggest that the growth factors critical for liver regeneration may not be involved in direct hyperplasia. Furthermore, mitogens such as ethylene dibromide and lead nitrate induce a rapid increase in TNF-a mRNA hepatic levels as well as an activation of the transcription factor NF-kB, one of the main targets of TNF-a. However, such changes were not observed following treatment with mitogens acting through receptors of the superfamily of hormone nuclear receptors (Menegazzi et al., 1997) . All together, these ®ndings suggest that TNF-a dependent and TNF-a independent, i.e. nuclear receptor-mediated, pathways leading to hepatocyte proliferation exist.
To directly test the role of TNF-a and IL-6-dependent signaling in the initiation of direct hyperplasia induced by primary mitogens of dierent nature, we analysed the growth response of hepatocytes in knock out mice lacking either TNFR-1 or IL-6. We report that in both cases mice respond as eciently as their wild type counterparts to proliferative stimuli induced by two primary mitogens, TCPOBOP (an halogenated hydrocarbon) (Manenti et al., 1987) and cipro®brate (CYP, a peroxisome proliferator) (Reddy et al., 1986) . Proliferation by these agents occurred without activation of STAT3, a major target of IL-6 and other cytokines/growth factors. These results demonstrate that although TNF-a and IL-6 appear to play a critical role in triggering liver regeneration, they are not necessarily required for initiation of hepatocyte proliferation. These results support the hypothesis that cell proliferation caused by certain primary mitogens may be triggered by signaling pathways dierent from those responsible for the transition of hepatocytes from G0-to G1 after PH or cell necrosis.
Results and discussion

TNFR-1 knock-out mice
We previously reported that TCPOBOP-induced hepatocyte proliferation, unlike compensatory regeneration, is not associated with increased hepatic mRNA levels of c-fos, c-jun, LRF-1 and other immediate early genes . Together with the observation that 24 h after TCPOBOP there is a higher number of hepatocytes entering S phase than that observed after PH, these ®ndings suggest that the signaling pathways leading to S phase entry after TCPOBOP are dierent. To directly test the role of TNF-a in TCPOBOP-induced liver cell proliferation, mice lacking the TNFR-1 receptor, and their normal counterparts, were treated with a single dose of TCPOBOP. BrdU (0.5 mg/ml) in drinking water was given 2 h after treatment to determine the labeling index of hepatocytes. Animals were sacri®ced after 3 days. Separate experiments showed that administration of BrdU in drinking water for 4 days resulted in a labeling index higher than 95% in CD-1 mice subjected to 2/3 PH, thus demonstrating a clear eectiveness of this protocol (Figure 1 ). Treatment with TCPOBOP caused no signs of liver cell damage, although an increased fat accumulation in hepatocytes from both wild and mutant mice was observed following mitogen administration. Labeling index of hepatocytes of TCPOBOP-treated mice (Figure 2 ), showed an almost similar response in both wild type as well as mutant type (15% and 20% of BrdU-positive hepatocytes, respectively) indicating that lack of TNFR-1 does not aect the proliferative response of hepatocytes to this mitogen. In addition, TCPOBOP did not induce any change in hepatic TNF-a mRNA levels (data not shown). These ®ndings suggest that TCPOBOP triggers hepatocyte proliferation through a TNF-independent pathway.
IL-6 knock out mice
IL-6 is a major regulator of the hepatic acute phase response in vivo and a STAT3 inducer (Trautwein et al., 1994; Ru-Jamison et al., 1993) . Its transcription is stimulated by TNF through NF-kB activation (Kishimoto et al., 1992) . Since it was previously reported that IL-6 de®ciency impairs liver regeneration for at least 4 ± 7 days (Cressman et al., 1996) , we have determined whether the absence of IL-6 could also inhibit the proliferative response of the liver to TCPOBOP. Results indicate that the extent of proliferation induced by TCPOBOP 4 days after treatment was similar in both mutant and wild type mice (50% and 43%, respectively versus 1% of oiltreated mice) (Figure 3 and 4a). The increased labeling index was associated to an increase in total hepatic DNA content (Figure 4b ). Therefore, lack of IL-6 does not aect the proliferative response of hepatocytes to this liver mitogen.
STAT3 activation following 2/3 PH or TCPOBOP
Activation of the transcription factor STAT3 has been suggested to play a critical role in regulating a cascade Figure 1 Labeling index of CD-1 mice 4 days after PH. Labeling index expressed as number of BrdU-positive hepatocyte nuclei/ 100 nuclei. BrdU (0.5 mg/ml) was dissolved in drinking water and given ad libitum for 4 days. At least 5000 hepatocyte nuclei per liver were scored in mice subjected to partial hepatectomy (PH) or sham operated (SO) Figure 2 Labeling index of TNFR-1 mouse hepatocytes following TCPOBOP. TNFR18 (KO) and wild type (WT) mice treated with a single dose of TCPOBOP (TCP, 3 mg/Kg, i.g.) or oil were sacri®ced 3 days later. Two hours after treatment, all mice were given BrdU (0.5 mg/ml in drinking water) until sacri®ced. At least 5000 hepatocyte nuclei per liver were scored. Labeling index was expressed as number of BrdU-positive hepatocyte nuclei/100 nuclei. Results are expressed as means+s.e. of 5 ± 6 mice per group of events leading to liver regeneration. In addition to IL-6, other molecules including Epidermal growth factor (EGF), may activate STAT3 (Ru-Jamison et al., 1994) . To determine whether STAT3 activation could still occur in TCPOBOP-induced hepatocyte proliferation via alternative mechanisms, gel shift assay was performed in both wild type and IL-6 7/7 mice. Livers from IL-6 +/+ mice subjected to 2/3 PH were also analysed as controls. As expected from previous studies, STAT3 activation is strongly induced 2 and 4 h after 2/3 PH (Figure 5a ) (Cressman et al., 1995) . On the contrary, no changes in STAT3 activation were observed after TCPOBOP treatment, neither in IL-6 7/7 or in IL-6 +/+ mice (Figure 5a ). From these results it can be concluded that STAT3 activation is not required for TCPOBOP-induced direct hyperplasia of the mouse liver. Similarly another transcription factor, AP-1, was activated in mouse liver following PH, but not in the liver of TCPOBOPtreated mice (Figure 5b ).
Liver cell proliferation by cipro®brate in IL-6 7/7 mice To determine whether the existence of TNF and IL-6 independent pathways in mouse liver cell proliferation is unique to TCPOBOP or a more general phenomenon, further experiments were conducted using the mitogen cipro®brate, a peroxisome proliferator (Reddy et al., 1986) . As shown in Figure 6 , the labeling index of the IL-6 7/7 mice hepatocytes was slightly higher than that of IL-6 +/+ mice, though the dierences were not statistically signi®cant because of individual variability. The results indicate that liver cell proliferation induced by this member of PP, in addition to TCPOBOP, occurs in the absence of IL-6 involvement.
STAT3 activation in rat liver following 2/3 PH or Nafenopin Nafenopin, like cipro®brate, is a peroxisome proliferator and a strong rat liver mitogen (Levine et al., 1977) . Previously, we have shown that a single dose of this agent does not induce activation of NF-kB or AP-1 (Menegazzi et al., 1997) . To determine whether hepatocyte proliferation induced by mitogens could occur in the absence of STAT3 activation also in rat, gel shift analysis was performed in animals given a single dose of nafenopin or subjected to 2/3 PH. While Figure 3 Representative microphotography which illustrates: (a), the presence of several BrdU-positive hepatocytes 4 days after TCPOBOP treatment in IL-6 +/+ , and (b), IL-6 7/7 mice. (X200, sections counterstained with hematoxylin) Figure 4 Labeling index of IL6 7/7 and IL-6 +/+ mouse hepatocytes and DNA content following TCPOBOP treatment. (a) IL-6 7/7 (KO) and wild type (WT) mice were treated with a single dose of TCPOBOP (TCP, 3 mg/Kg, i.g.), or oil, and sacri®ced 4 days later. Two hours after treatment, all mice were given BrdU (0.5 mg/ml in drinking water) until sacri®ce. At least 5000 hepatocyte nuclei per liver were scored. Labeling index was expressed as number of BrdU-positive hepatocyte nuclei/100 nuclei. Results are expressed as means+s.e. of 5 ± 6 mice per group; (b) Total hepatic DNA content in TCPOBOP and oil treated mice a rapid activation of STAT3 occurs after PH, no STAT3 activation could be observed at dierent times after Nafenopin treatment (Figure 7a ). In agreement with our previous results (Menegazzi et al., 1997) , Nafenopin-induced liver hyperplasia proceeds in the absence of activation of the transcription factor AP-1 (Figure 7b ).
Conclusions
We have shown that two dierent primary mitogens, TCPOBOP and cipro®brate induce liver cell proliferation in mice independent of TNFR-1 or IL-6. We have also shown that while the transcription factor STAT3, a main target of IL-6 and other cytokines and growth factors, is strongly activated after 2/3 PH in mouse and rat liver, there is no such an activation in mouse liver following a single administration of TCPOBOP nor in rat liver after administration of the peroxisome proliferator nafenopin. Together with previous findings indicating that certain rat or mouse hepatomitogens neither induce activation of NF-kB, nor stimulate hepatic transcription of immediate early genes (c-fos, cjun, LRF-1, egr-1 and c-myc) (Coni et al., 1993; Ohmura et al., 1996; Columbano et al., 1997) our HGF or TGF-a (Ohmura et al., 1996) , our results suggest that liver cell proliferation in the absence of cell loss/ death may occur through dierent signal transduction pathways.
It was previously suggested that PPs such as cipro®brate, exert their mitogenic eect through activation of PPARa, a member of steroid hormone nuclear receptor superfamily (Bardot et al., 1993) . The critical role of PPARa in hepatocyte proliferation induced by PP is supported by recent work on mice knock-out for this receptor (Peters et al., 1997) . On the other hand, no satisfactory explanation has yet been proposed for the mechanisms underlying the mitogenic eect of TCPOBOP. TCPOBOP is a Phenobarbital-like agent in respect to its ability to induce proliferation of smooth endoplasmic reticulum and P450 isozymes (Beebe et al., 1996; Honkakoski et al., 1992) . Phenobarbital is known to induce an Ah-receptorlike protein (Benedetti et al., 1994) that also binds TCDD. In several respects, the TCDD receptor is analogous to the peroxisome-proliferator activated receptor: both receptors have no known endogenous ligands clearly identi®ed, activate transcription of cytochrome P450 isoenzymes and bind DNA response elements that can potentially interfere with estrogen receptor transcriptional activity (Poellinger et al., 1992; White and Gasiewicz, 1993; Keller et al., 1995) . Whether the mitogenic activity of TCPOBOP is mediated through a receptor analogous to members of the nuclear receptor superfamily is not known. However, in view of the association between the Figure 6 Labeling index of IL6 7/7 and IL-6 +/+ mouse hepatocytes following cipro®brate. IL-6 7/7 (KO) and wild type (WT) mice were fed a cipro®brate-supplemented diet (CYP, 0.025%) or basal diet and killed 4 days afterwards. Two h after treatment, all mice were given BrdU (0.5 mg/ml in drinking water) for 4 days. At least 5000 hepatocyte nuclei per liver were scored. Labeling index was expressed as number of BrdU-positive hepatocyte nuclei/100 nuclei. Results are expressed as means+s.e. of 8 ± 10 mice per group Figure 5 DNA binding activity of STAT3 (a) and AP-1 (b) transcription factors in the liver of PH and TCPOBOP-treated mice. Nuclear extract from liver of mice killed at 2 and 4 h after PH or TCPOBOP administration were incubated with 32 P-labeled double stranded oligonucleotide containing the consensus sequence for STAT3 or AP-1 binding site mitogenic and carcinogenic eect of TCPOBOP in mouse liver, in depth studies might help to clarify the molecular basis of its action and, in particular, the possible existence of speci®c receptor(s) responsible for both mitogenic and tumorigenic eect of this chemical.
Materials and methods
Animals
TNFR-1 knock-out male mice (p55 7/7 ) of the B66129 strain (Rothe et al., 1993) and IL-6 7/7 female mice generated in 129 and backcrossed to C57/BL6 (Poli et al., 1994) were used in these experiments. The animals were fed a laboratory chow diet provided by Ditta Piccioni (Brescia, Italy) and had free access to food and water. All animals were acclimated 1 week before treatment, and the National Research Council criteria for the care and use of laboratory animals in research were followed. All experiments were performed in a temperature-controlled room with alternating 12 h dark/light cycles. TCPOBOP (3 mg/ Kg) was administered intragastrically in oil. Cipro®brate (CYP) was fed in the diet at a concentration of 0.025%. Cipro®brate was a kind gift from Sano® Winthrop (Guilford, UK). Nafenopin (NAF, 200 mg/Kg, in oil), was administered intragastrically to male Wistar rats (Charles River, Milano, Italy) and were sacri®ced at 1, 2 and 3 h thereafter. Two/third PH was performed according to Higgins and Anderson (1931) . Most treatments were performed between 9 and 12 am. For determination of hepatocyte proliferation, bromodeoxyuridine (BrdU) was given in drinking water at a ®nal concentration of 0.5 mg/ ml all throughout the experiment. Immediately after sacri®ce liver sections were ®xed in 10% buered formalin and processed for H&E staining or for immunohistochemistry. Remaining liver was frozen in liquid nitrogen and stored at 7808C for further studies.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from 200 mg of liver tissue according to Schreiber et al. (1989) in the presence of 10 mg/ml leupeptin, 5 mg/ml antipain and pepstatin, and 1 mM PMSF (Sigma Chemical Co.). Protein concentration in the nuclear extracts was determined using the method of Bradford (1976) . Eight micrograms of nuclear extracts were incubated at room temperature for 30 min with (2 ± 5610 4 ) of a 32 P-labeled double stranded oligonucleotide containing the sis-inducible factor binding recognition element (SIE/m67) from the c-fos promoter (5'-gtcgaCATTTCCCGTAAATCg-3') (Wagner et al., 1990) or the AP-1 DNA binding site (5'-CTAGTGATGAGTCAGCCG-GATC-3'), in a 15 ml reaction mixture containing 20 mM HEPES, pH 7.9, 50 mM KCl, 10% glycerol, 0.5 mM DTT, 0.1 mM EDTA, 2 mg poly(dI-dC), 1 mg salmon sperm DNA. Products were fractionated on a non-denaturing 5% polyacrylamide gel. In competition assays, 200-fold excess of competitor oligonucleotide was added 15 min before addition of the labeled probe. The intensity of the retarded bands was measured on a Phosphor Imager (Molecular Dynamics, Sunnyvale, CA, USA).
DNA hepatic content
After sacri®ce the livers were frozen at 7808C. Total hepatic DNA was quantitatively assayed from frozen tissue by Burton's diphenylamine method. (Burton, 1956 ). 
BrdU-Incorporation
Formalin-®xed sections were embedded in paran and deparaned sections processed for immunohistochemistry. BrdU incorporation into nuclei was determined immunohistochemically by the avidin-biotin-peroxidase complex (ABC) method using a mouse anti-BrdU monoclonal antibody (Becton Dickinson Immunocytometry Systems, San JoseÁ , CA) and Vectastain ABC kit (PK-4002, Vector Laboratories Inc., Burlingame, CA). In brief, tissue sections ®xed in 10% formalin were embedded in paran, deparanized, exposed to 0.3% hydrogen peroxide in ethanol for 10 min to block endogenous peroxidase, treated with 2N HCl, incubated with trypsin 0.1% for 20 min and then with normal horse serum for 20 min at room temperature. Sections were then incubated for 2 h with an anti-BrdU monoclonal antibody, followed by biotinylated horse anti-mouse IgG and avidin-biotin peroxidase complex. Sites of peroxidase binding were detected with diaminobenzidine (Graham and Karnovski, 1966) , and the sections were counterstained with hematoxylin. A segment of duodenum, an organ with a high rate of cell proliferation, was included from each mouse to con®rm delivery of the DNA precursor. At least 5000 hepatocyte nuclei per mouse were scored.
